Skip to main content
SpringerLink
Log in

Vascular Dementia and Parkinsonism

  • Chapter
  • First Online:
Movement Disorders in Dementias

Abstract

Cerebrovascular disease is a leading cause of mortality and morbidity worldwide. Its clinical manifestations vary from acute neurological deficit to stepwise or slowly progressive chronic deficits. Although originally described as separate entities, vascular dementia and vascular parkinsonism are overlapping spectrums of cognitive and extrapyramidal manifestations associated with subcortical vascular damage. In this chapter, we discuss the main concepts underlying the historical concepts of Binswanger encephalopathy and lower-body parkinsonism, present the main features of vascular dementia and vascular parkinsonism, summarize recommendations for clinical management, and close with suggestions for future research in these prevalent and often neglected conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ballard CG, Burton EJ, Barber R, Stephens S, Kenny RA, Kalaria RN, O’brien JT. NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology. 2004;63(6):983–8.

    Article  CAS  PubMed  Google Scholar 

  • Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten EC, van der Flier WM, Hsu C, Wu S, Lane R. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin. 2008;24(9):2561–74.

    Article  CAS  PubMed  Google Scholar 

  • Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34(10):2323–30.

    Article  CAS  PubMed  Google Scholar 

  • Bohnen NI, Muller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, et al. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson’s disease. Brain. 2011;134(Pt 8):2358–65.

    Article  PubMed Central  PubMed  Google Scholar 

  • Bradley WG, Daroff RB, Fenichel G, Jankovic J. Neurology in clinical practice. Philadelphia: Butterworth-Heinemann/Elsevier Saunders; 2008.

    Google Scholar 

  • Brewster PW, Mcdowell I, Moineddin R, Tierney MC. Differential prediction of vascular dementia and Alzheimer’s disease in nondemented older adults within 5 years of initial testing. Alzheimers Dement. 2012;8(6):528–35.

    Article  PubMed  Google Scholar 

  • Critchley M. Arteriosclerotic parkinsonism. Brain. 1929;52:23–83.

    Article  Google Scholar 

  • Critchley M. Arteriosclerotic pseudo-parkinsonism. Tunbridge Wells: Pitman Medical; 1981.

    Google Scholar 

  • Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand. 2001;104:63–7.

    Article  CAS  PubMed  Google Scholar 

  • Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomized trial. Lancet. 2002;359:1283–90.

    Article  PubMed  Google Scholar 

  • Erkinjuntti T, Roman G, Gauthier S. Treatment of vascular dementia–evidence from clinical trials with cholinesterase inhibitors. J Neurol Sci. 2004;226:63–6.

    Article  PubMed  Google Scholar 

  • Fitzgerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989;4:249–60.

    Article  CAS  PubMed  Google Scholar 

  • Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:745–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Glass P. Clinical features of vascular parkinsonism in pathologically confirmed cases. MSc thesis, UCL Institute of Neurology. London, 2012.

    Google Scholar 

  • Glass PG, Lees AJ, Bacellar A, Zijlmans J, Katzenschlager R, Silveira-Moriyama L. The clinical features of pathologically confirmed vascular parkinsonism. J Neurol Neurosurg Psychiatry. 2012;83(10):1027–9.

    Article  PubMed  Google Scholar 

  • Gorelick PB, Pantoni L. Advances in vascular cognitive impairment. Stroke. 2013;44(2):307–8.

    Article  PubMed  Google Scholar 

  • Hachinski VC, Lassen NA. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet. 1974;2:207–10.

    Article  CAS  PubMed  Google Scholar 

  • Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632–7.

    Article  CAS  PubMed  Google Scholar 

  • Jellinger KA. Vascular parkinsonism-neuropathological findings. Acta Neurol Scand. 2002;105:414–5.

    Article  CAS  PubMed  Google Scholar 

  • Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomized controlled trials. Lancet Neurol. 2007;6:782–92.

    Article  CAS  PubMed  Google Scholar 

  • Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1749–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mcshane R, Areosa AS, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2011;(3):CD003154.pub1.

    Google Scholar 

  • Mcguiness B, Ohare J, Craig D, et al. Statins for the treatment of dementia. Cochrane Database Syst Rev. 2010;(8):CD007514.

    Google Scholar 

  • Moroney JT, Bagiella F, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology. 1997;49:1096–105.

    Article  CAS  PubMed  Google Scholar 

  • Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pearce JMS. Binswanger’s “encephalitis subcorticalis chronica progressiva”. J Neurol Neurosurg Psychiatry. 1997;63:308. doi:10.1136/jnnp.63.3.308.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–9.

    Article  CAS  PubMed  Google Scholar 

  • Rampello L, Alvano A, Battaglia G, Raffaele R, Vecchio I, Malaguarnera M. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism. J Neurol. 2005;252:1045–9.

    Article  CAS  PubMed  Google Scholar 

  • Román CG, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINCDS-AIREN International Workshop. Neurology. 1993;43:250–60.

    Article  PubMed  Google Scholar 

  • Román GC. Facts, myths, and controversies in vascular dementia. J Neurol Sci. 2004;226(1–2):49–52.

    Article  PubMed  Google Scholar 

  • Sabbagh MN, Sparks DL. Statins to treat Alzheimer’s disease: an incomplete story. Expert Rev Neurother. 2012;12(1):27–30. doi:10.1586/ern.11.171.

    Article  CAS  PubMed  Google Scholar 

  • Santangelo G, Vitale C, Trojano L, de Gaspari D, Bilo L, Antonini A, Barone P. Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov Disord. 2010;25:50–6.

    Article  PubMed  Google Scholar 

  • Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011;(2):CD008191.

    Google Scholar 

  • Tang WK, Chan SS, Chiu HF, Ungvari GS, Wong KS, Kwok TC, Mok V, Wong KT, Richards PS, Ahuja AT. Impact of applying NINDS-AIREN criteria of probable vascular dementia to clinical and radiological characteristics of a stroke cohort with dementia. Cerebrovasc Dis. 2004;18(2):98–103.

    Article  PubMed  Google Scholar 

  • Vale TC, Barbosa MT, Caramelli P, Cardoso F. Vascular parkinsonism and cognitive impairment. Dement Neuropsychol. 2012;6(3):137–44.

    Google Scholar 

  • Wilcock G, Möbius HJ, Stöffler A, MMM 500 group. A double-blind, placebo-controlled, multicentre study of memantine in mild to moderate vascular dementia (MMM 500). Int Clin Psychopharmacol. 2002;17:197–305.

    Article  Google Scholar 

  • Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98–102.

    Article  CAS  PubMed  Google Scholar 

  • Witt K, Borsch K, Daniels C, et al. Neuropsychological consequences of endarterectomy and endovascular angioplasty with stent placement for treatment of symptomatic carotid stenosis. A prospective randomized study. J Neurol. 2007;254:1524–32.

    Article  PubMed  Google Scholar 

  • Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004a;19:630–40.

    Article  PubMed  Google Scholar 

  • Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ. The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry. 2004b;75:545–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zijlmans J, Evans A, Fontes F, et al. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson’s disease. Mov Disord. 2007;22:1278–85.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Hospital for Neurology and Neurosurgery, Reta Lila Weston Institute, UCL Institute of Neurology, Queen Square, London, UK

    Laura Silveira-Moriyama MD, PhD & Andrew J. Lees MD, FRCP

  2. Neurology Department, FCM, University of Campinas, UNICAMP, Hospital Das Clinicas, Campinas, SP, Brazil

    Laura Silveira-Moriyama MD, PhD

  3. Department of Neurology, University of Sao Paulo School of Medicine, Hospital Das Clinicas, Sao Paulo, SP, Brazil

    Egberto R. Barbosa MD, PhD

  4. Department of Internal Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

    Paulo Caramelli MD, PhD

  5. Department of Neurology, Amphia Hospital, Breda, NA, The Netherlands

    Jan Zijlmans MD, PhD

Authors
  1. Laura Silveira-Moriyama MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Egberto R. Barbosa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paulo Caramelli MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Zijlmans MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrew J. Lees MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Silveira-Moriyama MD, PhD .

Editor information

Editors and Affiliations

  1. Neuroscience Department, Universidad Catolica Argentina, Buenos Aires, Argentina

    Marcelo Merello

  2. Psychiatry and Clinical Neurosciences, University of Western Australia, Fremantle, Australia

    Sergio E. Starkstein

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Silveira-Moriyama, L., Barbosa, E.R., Caramelli, P., Zijlmans, J., Lees, A.J. (2014). Vascular Dementia and Parkinsonism. In: Merello, M., Starkstein, S. (eds) Movement Disorders in Dementias. Springer, London. https://doi.org/10.1007/978-1-4471-6365-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6365-7_12

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6364-0

  • Online ISBN: 978-1-4471-6365-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation